2-(4-chlorophenyl)-N-[3-[(2-chlorophenyl)sulfamoyl]-4-morpholin-4-ylphenyl]acetamide | 1033344-53-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: 2-(4-chlorophenyl)-N-[3-[(2-chlorophenyl)sulfamoyl]-4-morpholin-4-ylphenyl]acetamide
• CAS: 1033344-53-4
• 化学式: C₂₄H₂₃Cl₂N₃O₄S
• 分子量: 520.436
• InChiKey: FTGFTWHDTOHDQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.21
• 拓扑面积：
  96.1
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• Sulfonamides and their use as a medicament
  申请人：The Genetics Company, Inc.

  公开号：EP1932830A1

  公开（公告）日：2008-06-18

  The present invention relates to the use of a sulfonamide compound of formula I: wherein R1 is selected from the group consisting of H, CN, halogen, trifluoromethyl, methyl, ethyl, hydroxyl, methoxyl, ethoxyl, morpholinyl, R2 is selected from H, phenyl, substituted phenyl, CN, -SO2R, wherein R is phenyl or morpholinyl, -NC(O)Me, -NC(O)Et, - CH2C(O)OMe, CH2C(O)OEt, R3 is selected from the group consisting of H, NO2 NH2, halogen, -COOMe, -COOEt, RC(O)N-, morpholino, R4 is selected from the group consisting of H, a branched or unbranched methyl, ethyl, propyl, butyl, pentyl, methoxyl, ethoxyl, propoxyl, butoxyl, a substituted or unsubstituted phenyl, alkynyl, Me2SO2-, COOR, wherein R is a branched or unbranched methyl, ethyl, propyl, butyl, pentyl, - MeOC(O)-, a substituted or unsubstituted five or six-membered aromatic or non-aromatic heterocyclic system with one , two or three heteroatoms, a heteroaryl system, a condensed benzoheterocyclic system, X is a linker comprising 2 or 3 atoms, selected from the group consisting of -NH-NH-, -NH-NH-CH2-, ethynyl, -NH-C(O)-CH2-, -NH-NH-SO2- -C(O)-NH-CH2-, -NH-N=CH-, -NH-N=C(Me)-, a -NH-N=CH- motif being part of a heterocyclic system, preferably a substituted or unsubstituted pyrazole or pyridazine system, and pharmaceutically active salts thereof. Further, the invention relates to the use of these compounds as a medicament, especially for the treatment of cancer.

  本发明涉及使用式I的磺胺化合物： 其中 R1选自H、CN、卤素、三氟甲基、甲基、乙基、羟基、甲氧基、乙氧基、吗啉基中的一种； R2选自H、苯基、取代苯基、CN、-SO2R中的一种，其中R为苯基或吗啉基，-NC(O)Me、-NC(O)Et、- C(O)OMe、 C(O)OEt中的一种； R3选自H、NO2、NH2、卤素、-COOMe、-COOEt、RC(O)N-、吗啉基中的一种； R4选自H、支链或非支链的甲基、乙基、丙基、丁基、戊基、甲氧基、乙氧基、丙氧基、丁氧基、取代或未取代的苯基、炔基、Me2SO2-、COOR中的一种，其中R为支链或非支链的甲基、乙基、丙基、丁基、戊基、-MeOC(O)-、取代或未取代的五元或六元芳香或非芳香杂环系统，带有一个、两个或三个杂原子的杂环芳基系统，一个紧凑的苯并杂环系统，X是包含2或3个原子的连接物，选自-NH-NH-、-NH-NH-CH2-、乙炔基、-NH-C(O)- -、-NH-NH-SO2-、-C(O)-NH- -、-NH-N=CH-、-NH-N=C(Me)-、-NH-N=CH-基团是杂环系统的一部分，优选为取代或未取代的吡唑或吡啶嘧啶系统，以及其药用活性盐。此外，本发明涉及将这些化合物用作药物，特别用于癌症治疗。
• SULFONAMIDES AND THEIR USE AS A MEDICAMENT
  申请人：Garcia Gabriel

  公开号：US20100249135A1

  公开（公告）日：2010-09-30

  The present invention relates to the use of a sulfonamide compound of formula (I): wherein R 1 is selected from the group consisting of H, CN, halogen, trifluoromethyl, methyl, ethyl, hydroxy, methoxy, ethoxy, morpholino, R 2 is selected from H, phenyl, substituted phenyl, CN, —SO 2 R, wherein R is phenyl or morpholino, —NC(O)Me, —NC(O)Et, —CH 2 C(O)OMe, CH 2 C(O)OEt, R 3 is selected from the group consisting of H, NO 2 , NH 2 , halogen, —COOMe, —COOEt, RC(O)N—, morpholino, R 4 is selected from the group consisting of H, a branched or unbranched methyl, ethyl, propyl, butyl, pentyl, methoxy, ethoxy, propoxy, butoxy, a substituted or unsubstituted phenyl, alkinyl, Me 2 SO 2 —, COOR, wherein R is a branched or unbranched methyl, ethyl, propyl, butyl, pentyl, -MeOC(O)—, a substituted or unsubstituted five or sixmembered aromatic or non-aromatic heterocyclic system with one, two or three heteroatoms, a hetaryl system, a condensed benzoheterocyclic system, X is a linker comprising 2 or 3 atoms, selected from the group consisting of —NH—NH—, —NH—NH—CH2-, ethinyl, —NH—C(O)—CH 2 —, —NH—NH—SO 2 —, —C(O)—NH—CH 2 —, —NH—N═CH—, —NH—N═C(Me)-, a —NH—N═CH— motif being part of a heterocyclic system, preferably a substituted or unsubstituted pyrazole or pyridazine system, and pharmaceutically active salts thereof. Further, the invention relates to the use of these compounds as a medicament, especially for the treatment of cancer.
• US8088772B2
  申请人：——

  公开号：US8088772B2

  公开（公告）日：2012-01-03